Genzyme Issues Letters to Healthcare Providers about Drug Contamination (GENZ)
November 16th, 2009

Biotech company Genzyme Corporation (GENZ), which makes drug treatments for rare disorders, has sent letters to healthcare providers warning that some drugs from a certain plan may be contaminated with foreign particles.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!




RSS



Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the